|
HS Code |
676280 |
| Product Name | Vancomycin Hydrochloride |
| Cas Number | 1404-93-9 |
| Molecular Formula | C66H75Cl2N9O24 |
| Molecular Weight | 1485.71 g/mol |
| Purity | ≥90% (HPLC) |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Temperature | 2-8°C |
| Application | Antibiotic, cell culture |
As an accredited Vancomycin Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Vancomycin Hydrochloride from Sigma Aldrich arrives in a 5g amber glass bottle with a sealed screw cap and detailed labeling. |
| Shipping | Vancomycin Hydrochloride from Sigma-Aldrich/Merck/TCI Chemical is shipped in tightly sealed containers, protected from moisture and light. Packaging complies with regulatory standards for pharmaceuticals. Temperature control may be implemented if specified. Each shipment includes proper labeling, safety data sheets, and handling instructions to ensure safe and compliant delivery. |
| Storage | Vancomycin Hydrochloride should be stored at 2–8°C (refrigerated), protected from light and moisture. Keep the container tightly closed in a dry, well-ventilated place. Ensure it is stored away from incompatible substances. Follow Sigma-Aldrich, Merck, or TCI Chemical's specific MSDS and labeling guidelines for safe handling and storage. Proper storage maintains stability and prevents degradation of the chemical. |
Competitive Vancomycin Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In our work as a chemical manufacturer, Vancomycin Hydrochloride stands out as a product that demands precision at every stage. This antibiotic has earned its reputation for tackling resistant Gram-positive infections, which often stump lighter drugs. Each batch we produce is shaped by years of process refinement, rigorous quality checks, and real-world insight from customers who rely on consistency and reliability. Our people know the stakes inside hospitals and laboratories, and that understanding drives the way we handle this material.
Making Vancomycin Hydrochloride is anything but routine. We start with a carefully controlled fermentation process, using an actinobacterium strain that’s been studied and fine-tuned for maximum yield. Every variable, from growth medium composition to temperature, affects the end result. After fermentation, we pass the mixture through complex purification steps, removing unwanted byproducts so nothing interferes with the compound’s ability to work where it’s needed. Our dryers and crystallizers bring the product to a fine, white-to-ivory powder. Staff monitor output and run tests at each stage. No shortcut delivers the same level of confidence as direct oversight.
Specifications matter. While the industry standards typically require purity above 95%, our facility regularly exceeds that benchmark, aiming for minimal moisture and almost no visible extraneous particles. Finely tuned HPLC and microbiological assays run on each lot. Endotoxin levels fall well below pharmacopoeial limits. Packaging happens in dedicated suites, with air handling systems designed for pharmaceuticals. We’ve seen what lapses in cleanroom practice can do, so we engineer repeatability into every shift.
Purity isn’t just a number on a Certificate of Analysis. Any trace residuals can tip the scales in patient safety, especially for hospitals treating immunocompromised patients or newborns. Our analysts trace small variations in the molecular structure with advanced spectrometers. Shelf stability becomes critical in regions with warm storage conditions, so we invest in extra-deep lyophilization to extend usable life without cold chain dependence. Many customers in tropical countries have come to rely on those stability results. Any edge in stability can make the difference between a treatment that works and a stock that goes to waste.
Vancomycin Hydrochloride doesn't fit a one-size-fits-all approach. We craft several grades—most notably sterile and non-sterile forms. Sterile Vancomycin Hydrochloride is designed for direct compounding into injectables. Potential endotoxin exposure plunges with this grade, since we sterilize by filtration and monitor bioburden at multiple points. Non-sterile forms support research and development, where end-use scenarios allow for further processing. Some customers want bulk for formulation, others need smaller, premeasured aliquots for test runs. Our flexibility here comes from years spent solving specific client issues, not just reading specification sheets.
Differences from other antibiotics run deep. Vancomycin Hydrochloride isn’t a small molecule shaped on a traditional chemical reactor—it’s a glycopeptide, layered and complex. This means a more involved extraction, more sensitivity to handling, and more risk of denaturation if conditions shift. Beta-lactam antibiotics like penicillin or cephalosporins often show simpler solubility profiles and tolerate higher synthesis temperatures. We learn these distinctions the hard way, not in classrooms but on the production floor, where minor changes ripple into yield or stability swings.
Hospitals and clinics seek out Vancomycin Hydrochloride for tough infections that don’t respond to regular antibiotics. Using our product, pharmacy teams compound intravenous or oral solutions. Consistency batch after batch gives them the predictability they need. When our granulation and milling team fine-tune particle size, dissolving speed in saline or water goes up—important in emergency rooms where time matters. We keep close relationships with pharmacists to get feedback on ease of use, so changes can happen quickly if a batch pours slowly, clumps, or causes filtration issues.
End-users often need flexibility in dosing. Our packaging options—vials, multi-kilogram drums, single-use sachets—reflect these daily clinical realities. Due to contamination risks, we build anti-static features and tamper-evident closures into every batch run. Packages are checked for leaks, especially for international shipments where vibration and pressure change can break seals. No amount of theoretical planning replaces shipment data and photos from end-users showing intact or broken packages. As we scale up production, we build more real-time monitoring and anti-tampering measures to ensure customers receive exactly what they ordered.
Years of handling Vancomycin Hydrochloride have shown us how safety demands evolve. Staff training now extends beyond basic PPE—sterile technique and regular environmental monitoring are non-negotiable. Inhalation or skin exposure to powder presents risks our industry didn’t always recognize. HVAC upgrades, engineering controls, and waste management protocols continue improving as best practices change.
Our customers, especially those handling bulk chemicals, need guidance on minimizing occupational exposure. We publish firsthand recommendations on dust control, local exhaust ventilation, spill management, and staff rotation schedules—information shaped by real incidents, not just copied out of safety manuals. This partnership means more practical advice for customers and a cleaner safety record for everyone.
Talking to end-users reveals the strengths and gaps between various sources of Vancomycin Hydrochloride. Some global producers focus on raw output at the expense of detailed testing. Others buy intermediary products and finish to spec, resulting in variable quality from batch to batch. We devote resources to in-house manufacturing from start to finish. Whether it’s fermentation, purification, or packaging, we control every lever. Our ability to trace every bottle of powder back to a specific bioreactor means fewer surprises and faster recalls if anything goes wrong.
A number of clients mention difficulties when using generic or gray-market alternatives—residual solvent odors, erratic dissolution, or “off-color” product. Our process includes checks for trace organic solvents and a focus on strict clarity and color benchmarks. Visual appearance matters. Any batch not matching our in-house standard is sent back for reprocessing before release. We support more open communication about product failures because that’s how we spot and solve systemic issues. The goal isn’t just selling, but growing trust through transparent troubleshooting, even if that means eating the cost for a returned shipment.
As a manufacturer, sustainability runs deeper than company slogans. Fermentation produces significant waste that must be handled responsibly, both for regulatory compliance and local community relations. We treat water with precise filtration, biological digestion, and neutralization steps before it leaves the plant. Recoverable solvents and byproducts are recycled where possible. Monitoring data is logged and reviewed, forming the backbone of our reporting system. We work alongside environmental engineers and local authorities, building credibility through action—not advertising.
Some antibiotic manufacturing depends on older, more polluting processes. We invest heavily in vacuum distillation, closed-loop cooling, and energy recovery to keep our own footprint down. Equipment upgrades do cost more. Yet in the long term, these choices cut risk of regulatory noncompliance and repair community trust, especially as global scrutiny of pharmaceutical manufacturing grows. There’s no shortcut around investing in better process controls and cleaner power sources, especially as environmental standards tighten across trade partners.
Vancomycin Hydrochloride production keeps changing as standards get stricter and buyers become more demanding. Pharmacopoeial monographs evolve, and customer audits dig deeper than surface-level documentation. We regularly adapt our analytical arsenal, adding new tests for impurities or unknowns as the science moves forward. Meeting old standards isn’t enough if they don’t reflect current medical realities.
Supply chain risks came into sharp focus as raw material shipments stalled and global demand surged. Holding extra inventory, qualifying multiple sources for media, and developing self-sufficiency in precursor production helped us weather recent challenges. Each risk event taught us to eliminate single points of failure, building a more robust supply chain for our clients.
Working with research teams means adapting to unfamiliar project requirements. R&D clients sometimes need Vancomycin Hydrochloride formatted for high-throughput screening or novel formulations (liposomal, sustained-release, etc.). We supply custom-milled lots and tailor particle size distributions when needed. Pilot runs often expose subtle performance gaps, which we feed back into mainline production. We see ourselves as solution partners, not just suppliers, and get real satisfaction when a development scientist calls us directly to work through questions about solubility or compatibility.
Pharmacies and hospitals in resource-limited settings face unique supply, storage, and training issues. Our technical teams provide practical advice on reconstitution, dilution, and shelf-life extension, ideas informed by actual field visits. Some facilities run on erratic refrigeration or face staffing shortages, requiring tweaks in pack size, packaging, and handling instructions. These real-world adjustments grow from working relationships, not sales scripts.
Traceability, documentation, and data integrity weigh heavily on our day-to-day work. Regulators expect not just compliance, but deep documentation at every stage. Our team keeps double records—in paper and digital lines—so any deviation is flagged and investigated instantly. Auditors and inspectors regularly review our deviation logs, batch records, and result sheets. We keep documentation accessible and understandable, since cryptic spreadsheets frustrate both regulators and our own quality teams.
In different regions, standards for allowable impurities or shelf life may not match, meaning our product batches need customization to local rules. We’ve designed flexible documentation systems so different national requirements can be met without changing our core data structure. That comes from years of grappling with shifting guidelines—nothing beats experience for finding simple ways to demonstrate compliance.
Experience teaches that each batch of Vancomycin Hydrochloride entering the medical system carries the weight of trust. Our commitment is not just to specifications or paperwork but to the people and patients whose lives depend on tested, reliable product. Quick feedback loops, rigorous staff training, and visible accountability keep the process honest.
As resistance shifts and healthcare needs keep growing, the focus will keep falling on products like Vancomycin Hydrochloride. Our job doesn’t stop at a clean Certificate of Analysis—it stretches into building resilience, learning from setbacks, and pushing for improvements driven by customer realities as much as laboratory data. Every question, reformulation, or returned package drives future innovation.
Vancomycin Hydrochloride draws together the best and toughest parts of chemical manufacturing. From the sensitivity of fermentation to the strict standards of final QC, every step calls for expertise and care. No generic answer or shortcut stands in for real manufacturing experience. We meet the challenge by staying close to our customers, our processes, and our core standards—the only way we know to keep delivering a product that meets the real-world needs of hospitals, labs, and patients who count on it.